Procalcitonin-Guided Antibiotic Therapy
Effects of Using Procalcitonin To Guide Antibiotic Therapy in Postoperative Patients
Evidence was insufficient to determine if procalcitonin guidance can identify postoperative patients at risk of developing infections who might benefit from pre-emptive antibiotic therapy. A single study evaluated outcomes in 20 postoperative patients with elevated procalcitonin levels who were randomized to receive either prophylactic or pre-emptive antibiotic therapy or standard care (control). Procalcitonin-guided pre-emptive antibiotic therapy reduced the duration of antibiotic therapy by 3.5 days when compared with the control arm; however, this difference was not statistically significant. Patients in the control arm had a significantly prolonged hospital length of stay (12 days longer; P = 0.057) and a significantly higher incidence of systemic infection (P = 0.07). However, due to small size of the study, the strength of evidence for this finding was rated insufficient.
Keywords: antibiotic therapy | bacterial infection | clinical question | finding | outcome | postoperative | procalcitonin | strength of evidence | key question
- Soni NJ, Samson DJ, Galaydick JL, et al. Procalcitonin-Guided Antibiotic Therapy. Comparative Effectiveness Review No. 78 (Prepared by the Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-based Practice Center under Contract No. HHSA 290-2007-10058-I). Rockville, MD: Agency for Healthcare Research and Quality; August 2012. AHRQ Publication No. 12-EHC124-EF. Available at www.effectivehealthcare.ahrq.gov/procalcitonin.cfm.
Your slide tray is being processed.